Ozempic/Mounjaro Unpacked: RN & COO Nikkalena Caforio on Myths, Risks & Results

Guest: Nikkalena Caforio, RN — Chief Operating Officer at Authentic Medical Weight Loss & Wellness — joins Kim to unpack what stylists and clients really need to know about GLP-1 weight-loss medications (Ozempic, Wegovy, Mounjaro/Zepbound). They dig into who qualifies, the ethics around “a few pounds,” the compounding ban, cost and insurance, what happens when you stop, side effects and safety guardrails, why you must pause before anesthesia, hair loss (telogen effluvium), “Ozempic face,” and where GLP-1s are headed next.In this episode:Medical need vs. vanity: how clinicians draw the lineCompounded products, “gummies,” and what changedCost/coverage realities & whether GLP-1s are lifelongRegain risk after stopping and how clinics taperScreenings & red flags (retinopathy, thyroid, GI)Anesthesia protocols you should knowHair loss: why it happens and what actually helpsThe “Ozempic face” conversation, kindly and clearlyThe future of GLP-1s: prevention and accessGuest links:Website: https://www.authenticmedicalpllc.com/Instagram: @authentic_medical_ (https://instagram.com/authentic_medical_)Nikkalena’s IG: @nursenikk_am (https://instagram.com/nursenikk_am)Kim’s links:Instagram: https://www.instagram.com/trendywkimallison/Youtube: https://youtu.be/Ot5QE1l2ooETikTok: @trendywithkimallisonWebsite: www.kimallison.netDisclaimer: This podcast is for informational purposes only and does not constitute medical advice. Please consult your healthcare provider.Subscribe to stay in the know. Message me to possibly be a guest on the show. Hosted on Acast. See acast.com/privacy for more information.